California Statutes

§ 127694. — 127694. (Amended by Stats. 2022, Ch. 47, Sec. 22.)

California § 127694.
JurisdictionCalifornia
Code HSCHealth and Safety Code - HSC
Div. 107.DIVISION 107. HEALTH CARE ACCESS AND INFORMATION
Part 2.PART 2. HEALTH POLICY AND PLANNING
Ch. 10.CHAPTER 10. California Affordable Drug Manufacturing Act of 2020

This text of California § 127694. (127694. (Amended by Stats. 2022, Ch. 47, Sec. 22.)) is published on Counsel Stack Legal Research, covering California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cal. Health and Safety Code - HSC Code § 127694. (2026).

Text

(a)On or before December 31, 2023, CHHSA shall submit a report to the Legislature that assesses the feasibility of directly manufacturing generic prescription drugs and selling generic prescription drugs at a fair price. The report shall include an analysis of governance structure options for manufacturing functions, including chartering a private organization, a public-private partnership, or a public board of directors.
(b)This section shall only go into effect if the Legislature appropriates funds for this purpose in the annual budget.
(c)The report shall be submitted in compliance with Section 9795 of the Government Code.
(d)This section shall remain in effect only until January 1, 2028, and as of that date is repealed.

Free access — add to your briefcase to read the full text and ask questions with AI

Legislative History

Amended by Stats. 2022, Ch. 47, Sec. 22. (SB 184) Effective June 30, 2022. Repealed as of January 1, 2028, by its own provisions.

Nearby Sections

2
View on official source ↗

Cite This Page — Counsel Stack

Bluebook (online)
California § 127694., Counsel Stack Legal Research, https://law.counselstack.com/statute/ca/HSC/127694..